| Rapid UTI Diagnostics in Lower Urinary Tract Dysfunction Among Catheter Users NCT07784829 Medstar Health Research Institute | Henüz hasta almıyor | Uygulanmaz | Eyl 2026 |
| NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome NCT07278492 Brigham and Women's Hospital | Henüz hasta almıyor | Faz 1 | 31 Ağustos 2026 |
| Efficacy of Topical Niacinamide Riboside on the Signs of Facial Skin Aging NCT07774000 ChromaDex, Inc. | Hasta alıyor | Uygulanmaz | 17 Ağustos 2026 |
| NAD Supplementation in Parkinson's Disease NCT07703137 University of Oklahoma | Davetle katılım | Uygulanmaz | 10 Ağustos 2026 |
| A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults NCT07692633 Reus Research | Henüz hasta almıyor | Uygulanmaz | Ağu 2026 |
| Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer. NCT07394946 Cancer Care Hospital & Research Centre Foundation, Lahore | Henüz hasta almıyor | Faz 2 | Haz 2026 |
| Edaravone Dexborneol for Post-Stroke Epilepsy NCT07604350 First Affiliated Hospital of Wenzhou Medical University | Henüz hasta almıyor | Faz 3 | Haz 2026 |
| A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders NCT07579741 Jecho Biopharmaceuticals Co., Ltd. | Hasta alıyor | Faz 1, Faz 2 | 26 Mayıs 2026 |
| Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial) NCT07579429 University of Colorado, Denver | Hasta alıyor | Faz 2 | 20 Mayıs 2026 |
| Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension NCT07563322 Vanderbilt University Medical Center | Hasta alıyor | Uygulanmaz | 9 Nisan 2026 |
| Brain NAD in Alzheimer's Disease NCT07127510 Florida Atlantic University | Hasta alıyor | — | 18 Mart 2026 |
| Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy NCT07436182 Mansoura University | Henüz hasta almıyor | Faz 4 | 1 Mart 2026 |
| A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors NCT07229638 Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hasta alıyor | Faz 1, Faz 2 | 27 Şubat 2026 |
| Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults NCT07144527 Scott Silveira | Hasta alıyor | Uygulanmaz | 21 Şubat 2026 |
| The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response NCT06983730 Beth Israel Deaconess Medical Center | Hasta alıyor | Erken faz 1 | 26 Ocak 2026 |
| Efficacy and Safety of Coenzyme I for Injection on Vascular Aging. NCT07328100 Shanghai 10th People's Hospital | Henüz hasta almıyor | Uygulanmaz | 16 Ocak 2026 |
| Our Peers - Empowerment and Navigational Support - Community Living (OP-ENS-CL): A Peer Navigator Intervention for Adults With Acquired Physical Disabilities NCT06941233 Susan Magasi | Hasta alıyor | Uygulanmaz | 1 Aralık 2025 |
| NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals NCT06971224 Haukeland University Hospital | Hasta alıyor | Faz 2 | 13 Ekim 2025 |
| POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS NCT07178964 University Medical Centre Ljubljana | Henüz hasta almıyor | Uygulanmaz | 1 Ekim 2025 |
| Nicotinamide Levels in Serum, Aqueous Humor, and Tear Film in Glaucoma and Correlations With Mitochondrial Damage-Associated Molecular Patterns (mtDAMPs) and Senescence-Associated Secretory Phenotype (SASP) NCT07006194 Università degli Studi 'G. d'Annunzio' Chieti e Pescara | Henüz hasta almıyor | Uygulanmaz | 1 Ekim 2025 |
| Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication NCT07255378 Jamil Cedeño Mora | Hasta alıyor | — | 1 Ekim 2025 |
| Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression NCT06866236 Ebima Clifford Okundaye | Henüz hasta almıyor | Faz 2, Faz 3 | Eki 2025 |
| Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide Prevention in Mozambique NCT06465381 University of Washington | Hasta alıyor | Uygulanmaz | 1 Eylül 2025 |
| Tailored Vs. Empirical Helicobacter Pylori Infection Treatment NCT06200779 Manuel Coelho da Rocha | Henüz hasta almıyor | Faz 4 | Eyl 2025 |
| The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC NCT06965829 Shanghai Chest Hospital | Henüz hasta almıyor | Faz 2 | 1 Temmuz 2025 |
| Movement Improves Brain Health and Cognition in Parkinson's Disease NCT07299279 Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Hasta alıyor | Uygulanmaz | 9 Haziran 2025 |
| Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients NCT06991712 Christopher Kai Shun Leung | Hasta alıyor | Faz 2 | 19 Mayıs 2025 |
| NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC NCT06966583 Sichuan University | Henüz hasta almıyor | Faz 1 | 1 Mayıs 2025 |
| Tracing the Metabolic Flux of Orally Administered NAD+ Precursors NCT06882096 Metro International Biotech, LLC | Hasta alıyor | Faz 1 | 28 Nisan 2025 |
| ACEs, SIRT1, and Premature Vascular Aging in Humans NCT07073352 University of Wisconsin, Madison | Hasta alıyor | Uygulanmaz | 27 Mart 2025 |
| The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease NCT06853743 Oslo University Hospital | Hasta alıyor | Faz 2 | 18 Mart 2025 |
| Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Care (NI-AKI) NCT07203131 GCS Ramsay Santé pour l'Enseignement et la Recherche | Hasta alıyor | Uygulanmaz | 17 Mart 2025 |
| Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess NCT06847126 Post Graduate Institute of Medical Education and Research, Chandigarh | Hasta alıyor | Faz 3 | 25 Şubat 2025 |
| Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults NCT06815991 Metro International Biotech, LLC | Hasta alıyor | Faz 1 | 11 Şubat 2025 |
| A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia NCT06776510 Institute of Hematology & Blood Diseases Hospital, China | Hasta alıyor | Faz 1, Faz 2 | 15 Ocak 2025 |
| EFFECT OF CIRCUIT TRAINING ON BONE MINERAL DENSITY IN POST MENOPAUSAL PERIOD NCT06950463 Cairo University | Hasta alıyor | Uygulanmaz | 1 Ocak 2025 |
| The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging NCT06208527 Haukeland University Hospital | Hasta alıyor | Faz 2 | Oca 2025 |
| A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors NCT06726369 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Hasta alıyor | Faz 1 | 12 Aralık 2024 |
| The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT NCT06558253 Anhui Provincial Hospital | Hasta alıyor | Faz 1 | 29 Kasım 2024 |
| Nicotinamide Adenine Dinucleotide (NAD+) Metabolism in Human Brown Adipose Tissue NCT06627868 University of Turku | Hasta alıyor | Uygulanmaz | 20 Kasım 2024 |